+987.9%
MRNA vs DKS
-29.5%
+1,017.4%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | DKS | Excess | Alpha |
|---|---|---|---|---|
| 1D | +13.1% | +7.7% | +5.4% | +12.2% |
| 7D | +20.6% | +8.4% | +12.2% | +19.5% |
| 30D | +27.1% | +7.7% | +19.5% | +25.6% |
| 3M | +353.4% | -25.8% | +379.1% | +389.1% |
| 6M | +446.3% | -31.0% | +477.3% | +505.9% |
| YTD | +776.2% | -23.8% | +800.0% | +807.3% |
| 1Y | +987.9% | -29.8% | +1,017.7% | +1,076.4% |
| All | +987.9% | -29.5% | +1,017.4% | +1,076.4% |
Cumulative growth
Daily Returns
Daily percentage return beside DKS.
Daily Out/Under-Performance
Portfolio return minus DKS return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × DKS return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded DKS wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling